Kronos Bio Stock Revenue
| KRONDelisted Stock | USD 0.88 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Kronos Bio's long-term financial health and intrinsic value.
Kronos |
Kronos Bio Company Revenue Analysis
Kronos Bio's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Kronos Bio Revenue | 9.85 M |
Most of Kronos Bio's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kronos Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Kronos Bio reported 9.85 M of revenue. This is 99.87% lower than that of the Biotechnology sector and 98.67% lower than that of the Health Care industry. The revenue for all United States stocks is 99.9% higher than that of the company.
Kronos Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kronos Bio's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kronos Bio could also be used in its relative valuation, which is a method of valuing Kronos Bio by comparing valuation metrics of similar companies.Kronos Bio is currently under evaluation in revenue category among its peers.
Kronos Fundamentals
| Return On Equity | -0.59 | |||
| Return On Asset | -0.22 | |||
| Operating Margin | (3.42) % | |||
| Current Valuation | (21.99 M) | |||
| Shares Outstanding | 60.97 M | |||
| Shares Owned By Insiders | 24.26 % | |||
| Shares Owned By Institutions | 31.43 % | |||
| Number Of Shares Shorted | 754.26 K | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 5.84 X | |||
| Revenue | 9.85 M | |||
| Gross Profit | 9.19 M | |||
| EBITDA | (61.72 M) | |||
| Net Income | (86.08 M) | |||
| Cash And Equivalents | 267.89 M | |||
| Cash Per Share | 4.72 X | |||
| Total Debt | 24.9 M | |||
| Debt To Equity | 0.11 % | |||
| Current Ratio | 15.07 X | |||
| Book Value Per Share | 1.31 X | |||
| Cash Flow From Operations | (65.44 M) | |||
| Short Ratio | 0.60 X | |||
| Earnings Per Share | (1.07) X | |||
| Target Price | 2.25 | |||
| Beta | 1.64 | |||
| Market Capitalization | 53.65 M | |||
| Total Asset | 124.36 M | |||
| Retained Earnings | (594.94 M) | |||
| Working Capital | 99.95 M | |||
| Net Asset | 124.36 M |
About Kronos Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kronos Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kronos Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kronos Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Kronos Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kronos Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will appreciate offsetting losses from the drop in the long position's value.Moving against Kronos Stock
| 0.61 | INTC | Intel | PairCorr |
| 0.6 | AXP | American Express | PairCorr |
| 0.54 | CWCO | Consolidated Water Earnings Call This Week | PairCorr |
| 0.51 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.47 | CSCO | Cisco Systems Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Kronos Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kronos Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kronos Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kronos Bio to buy it.
The correlation of Kronos Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kronos Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kronos Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kronos Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Kronos Stock
If you are still planning to invest in Kronos Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kronos Bio's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |